Keimyung University Dongsan Hospital — Daegu

Public research footprint of Keimyung University Dongsan Hospital, compiled from the ClinicalTrials.gov public registry.

200

Registered studies

102

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Post- Essential Thrombocythemia Myelofibrosis · Urinary Bladder Neoplasms · Endometrial Cancer

Recently updated registry entries

NCT06902558 — ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult… (Recruiting)
NCT06979362 — A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and… (Recruiting)
NCT07746895 — Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Keimyung University Dongsan Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.